货号:GS40274
Fontolizumab was an investigational, humanized monoclonal antibody developed for the treatment of inflammatory and autoimmune diseases, particularly Crohn's disease. It functioned as a targeted interferon-gamma (IFN-γ) inhibitor. By binding to and neutralizing IFN-γ in the bloodstream, fontolizumab aimed to suppress the activity of this key pro-inflammatory cytokine, which is central to the Th1-mediated immune response implicated in the pathogenesis of Crohn's disease. The goal was to reduce the excessive inflammation in the intestinal tract and induce clinical remission.
科技型中小企业
高新技术企业
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯